Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$13M |
 |
AstrazenecaAZN |
-$480,000 |
 |
Johnson & JohnsonJNJ |
-$631M |
 |
ModernaMRNA |
-$1.8B |
 |
AbbVieABBV |
-$378M |
Are Lifecore Biomedical Insiders Buying or Selling?
Lifecore Biomedical (LFCR) has had no reported insider transactions in the past 90 days. The most recent was LP 22NW,, who sold 150,419 shares at $7.12 on May 28, 2025.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the LFCR AI Score. For government officials trading this stock, see LFCR congressional trading.
Who’s Trading Lifecore Biomedical Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| LP 22NW, | Sold $9.9M | 10 | May 28, 2025 |
| Paul Josephs | Bought $98,000 | 1 | Jan 8, 2025 |
Recent Lifecore Biomedical Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| LP 22NW, | May 28, 2025 | Sell | 150,419 | $7.12 | $1.1M |
| LP 22NW, | May 27, 2025 | Sell | 1,139,504 | $6.5 | $7.4M |
| LP 22NW, | May 23, 2025 | Sell | 96,137 | $6.75 | $650,000 |
| LP 22NW, | May 13, 2025 | Sell | 12,334 | $7 | $86,000 |
| LP 22NW, | May 12, 2025 | Sell | 45,698 | $7.03 | $320,000 |
| LP 22NW, | May 9, 2025 | Sell | 700 | $7 | $4,900 |
| LP 22NW, | May 8, 2025 | Sell | 5,098 | $7 | $36,000 |
| LP 22NW, | May 7, 2025 | Sell | 15,847 | $7.01 | $110,000 |
| LP 22NW, | May 6, 2025 | Sell | 701 | $7.05 | $4,900 |
| LP 22NW, | May 5, 2025 | Sell | 24,543 | $7.08 | $170,000 |
| Paul Josephs | Jan 8, 2025 | Buy | 17,000 | $5.74 | $98,000 |
Frequently Asked Questions: Lifecore Biomedical Insider Trading
Lifecore Biomedical insiders have not reported any transactions in the past 90 days.
The most recent sale was by LP 22NW, who sold 150,419 shares on May 28, 2025. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Josephs Paul has bought the most LFCR stock in the last 2 years, with a total value of $98,000.
22NW, LP has sold the most LFCR stock in the last 2 years, with a total value of $9.9M.
The total value of insider transactions for Lifecore Biomedical in the last 2 years is negative, amounting to -$9.8M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
